4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091438
Chief Financial Officer sold 7,909 shares at $14.52 ($114,851)
From the SEC's structured data for this filing
Trades in this filing
FRATES JAMES M · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form | −7,909 | $14.52 | $114,851 | 165,638 | D |
| Open-market sales · 7,909 sh · avg $14.52 · $114,851 | ||||||
Loading xslF345X05/ownership.xml…